Skip to main content
Journal cover image

ASO Author Reflections: Towards Personalized Cancer Therapy: The Role of ctDNA as a Biomarker in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.

Publication ,  Journal Article
Liu, A; Strickler, J; Uronis, H; Lidsky, ME
Published in: Ann Surg Oncol
October 2025

Duke Scholars

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

October 2025

Volume

32

Issue

10

Start / End Page

7254 / 7255

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, A., Strickler, J., Uronis, H., & Lidsky, M. E. (2025). ASO Author Reflections: Towards Personalized Cancer Therapy: The Role of ctDNA as a Biomarker in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion. Ann Surg Oncol, 32(10), 7254–7255. https://doi.org/10.1245/s10434-025-17886-6
Liu, Annie, John Strickler, Hope Uronis, and Michael E. Lidsky. “ASO Author Reflections: Towards Personalized Cancer Therapy: The Role of ctDNA as a Biomarker in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.Ann Surg Oncol 32, no. 10 (October 2025): 7254–55. https://doi.org/10.1245/s10434-025-17886-6.
Journal cover image

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

October 2025

Volume

32

Issue

10

Start / End Page

7254 / 7255

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis